Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank29
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-22.36M
Near historical average
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-22.84M
Historical baseline
PeriodValueYoY Change
TTM$-22.36M+56.6%
2024$-51.49M-32.8%
2023$-38.77M-35.2%
2022$-28.67M-19.5%
2021$-23.98M-61.1%
2020$-14.89M-7.1%
2019$-13.90M-5.7%
2018$-13.16M-9.1%
2017$-12.05M-32.6%
2016$-9.09M-